Skip to main content

Table 1 Factorial design results

From: Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin

Batch

Particle size (mean ± SD, nm)

Zeta potential (mean ± SD, mV)

Percent drug entrapment (mean ± SD, %)

SLN 1

145 ± 0.57a

20.7 ± 0.22a

62.88 ± 0.99

156 ± 0.64b

15.8 ± 0.13b

SLN 2

168 ± 0.43a

20.2 ± 0.17a

64.21 ± 0.83

179 ± 0.27b

15.4 ± 0.14b

SLN 3

218 ± 0.39a

19.7 ± 0.13a

67.11 ± 0.42

226 ± 0.44b

14.9 ± 0.11b

SLN 4

158 ± 0.55a

17.5 ± 0.22a

82.32 ± 0.89

165 ± 0.56b

13.5 ± 0.19b

SLN 5c

188 ± 0.97a

16.8 ± 0.33a

84.99 ± 0.73

194 ± 0.89b

12.43 ± 0.26b

SLN 6

221 ± 0.6a

16.4 ± 0.11a

85.91 ± 0.64

229 ± 0.41b

12.1 ± 0.17b

SLN 7

164 ± 0.41a

14.3 ± 0.12a

86.58 ± 0.78

172 ± 0.66b

9.6 ± 0.11b

SLN 8

206 ± 0.99a

13.8 ± 0.099a

87.22 ± 0.85

214 ± 0.75b

9.3 ± 0.1b

SLN 9

228 ± 0.54a

13.6 ± 0.092a

89.02 ± 0.66

239 ± 0.48b

8.9 ± 0.098b

  1. aB-SLN
  2. bC-SLN
  3. cOptimized batch